MONEYVIEW vs NIVABUPA: Stock Comparison
NIVA BUPA HEALTH INS CO L is the larger company by market capitalisation. NIVA BUPA HEALTH INS CO L shows faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
MONEYVIEW leads 0; NIVABUPA leads 3 of 4
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | MONEYVIEW | NIVABUPA |
|---|---|---|
| Sector | — | Financial Services |
| Industry | — | General Insurance |
Price
| Metric | MONEYVIEW | NIVABUPA |
|---|---|---|
| Live Price | ₹62.39 | ₹77.65 |
| Day Change | 7.77% | -0.23% |
| Volume | 45.1 Cr | 8.87 L |
| 52-Week High | ₹64.56 | ₹91.4 |
| 52-Week Low | ₹48.34 | ₹67.5 |
| Distance from 52W High | -3.36% | -15.04% |
Valuation
| Metric | MONEYVIEW | NIVABUPA |
|---|---|---|
| Market Cap | ₹11,014 Cr | ₹14,330 Cr |
| P/E Ratio | — | 109.27x |
| P/B Ratio | — | 3.77x |
| EPS | — | ₹1.87 |
| Book Value | — | ₹22.59 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | MONEYVIEW | NIVABUPA |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 26.8% |
| EPS Growth (TTM YoY) | 0% | 90.2% |
Profitability & Leverage
Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.| Metric | MONEYVIEW | NIVABUPA |
|---|---|---|
| ROE | — | 0% |
| ROCE | — | 0% |
| Net Margin | 0% | 4.34% |
| Debt to Equity | — | 0.07x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | MONEYVIEW | NIVABUPA |
|---|---|---|
| Promoter Holding | 19.31% | 0% |
| FII Holding | 59.9% | 12.09%▲ 1.49 pp |
| DII Holding | 7.5% | 16.17%▼ 0.32 pp |
| Public Holding | 12.59% | 16.44%▼ 1.11 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: MONEYVIEW and NIVA BUPA HEALTH INS CO L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.